SCHEMBL21452934

SCHEMBL21452934

Cc1nc(-c2ccc(OC(F)(F)F)c(C)c2)cc(N2CCC[C@@H](F)C2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 1/20 0.42
▸ MAP3K12 Q12852 7/20 0.39
▸ GRM2 Q14416 8/20 0.37
▸ SCN5A Q14524 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ USP2 O75604 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ CHRM3 P20309 1/20 0.34
▸ PDE4A P27815 1/20 0.34
▸ PDE4B Q07343 1/20 0.34
▸ PDE4C Q08493 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21453034 0.87 KMT2A (0.47) KMT2AMAP3K12SCN5AKDM4EALDH1A1
SCHEMBL21452862 0.80 KMT2A (0.44) KMT2AMAP3K12GRM2CHRM3PDE4A
SCHEMBL23992108 0.79 SMPD3 (0.39) GRM2CHRM3
SCHEMBL21434037 0.79 SMPD3 (0.39) GRM2CHRM3
SCHEMBL21434036 0.79 SMPD3 (0.39) GRM2CHRM3
SCHEMBL21452656 0.78 SMPD3 (0.39) GRM2
SCHEMBL21434139 0.77 SMPD3 (0.45) —
SCHEMBL21434135 0.77 KMT2A (0.53) KMT2AGRM2KDM4EUSP2ALDH1A1
SCHEMBL21434064 0.75 KMT2A (0.43) KMT2AGRM2KDM4EALDH1A1
SCHEMBL21453053 0.75 FAAH (0.43) MAP3K12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019193516-A2 SUBSTITUTED PYRIDINE AND PYRIMIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2019-10-10 — — WO disclosed
Send feedback